These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2419672)

  • 21. Cardiovascular effects of ketanserin in closed-chest anesthetized dogs.
    van de Water A; Wouters L; Xhonneux R; Reneman S
    Arch Int Pharmacodyn Ther; 1985 Jun; 275(2):267-78. PubMed ID: 3161481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular and blood gas responses to ketanserin in canine pulmonary edema induced by oleic acid.
    Koyama S; Kiyono S; Kayaba K; Kimura M; Nishizawa M
    Anesthesiology; 1985 Apr; 62(4):457-61. PubMed ID: 3157333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and large arteries' compliance in humans: a cross-over double-blind study.
    De Luca N; Rosiello G; Crispino M; Volpe M; Galletti P; Buzzetti G; Trimarco B
    J Clin Pharmacol; 1988 Apr; 28(4):332-8. PubMed ID: 3292598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ketanserin versus sodium nitroprusside in the treatment of hypertension following coronary surgery. Effect on intrapulmonary right and left shunt and arterial oxygenation].
    Möllhoff T; Mulier JP; Müller E; Van Aken H; Lauwers P
    Anaesthesist; 1989 Oct; 38(10):519-24. PubMed ID: 2686485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketanserin in the treatment of systemic hypertension during and following coronary artery bypass surgery.
    van der Starre PJ; Reneman RS; Scheijgrond HW
    Angiology; 1989 Nov; 40(11):1001-10. PubMed ID: 2510560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and haemodynamic effects of ketanserin in lean and obese hypertensive patients.
    Licata G; Scaglione R; Parrinello G; Capuana G; Mazzola G; Lipari R; Castello R; Galantino L
    J Int Med Res; 1990; 18(2):112-9. PubMed ID: 2340944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic effects of ketanserin following coronary artery bypass grafting.
    Lee EJ; Lee TL; Woo M; Boey WK; Kumar A; Lee CN
    Anaesth Intensive Care; 1991 Aug; 19(3):351-6. PubMed ID: 1767902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of urapidil, ketanserin and sodium nitroprusside on venous admixture and arterial oxygenation following coronary artery bypass grafting.
    Möllhoff T; Van Aken H; Mulier JP; Müller E; Lauwers P
    Br J Anaesth; 1990 Apr; 64(4):493-7. PubMed ID: 2334625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ketanserin in essential hypertension: a double-blind, placebo-controlled study.
    Cameron HA; Ramsay LE
    Postgrad Med J; 1985 Jul; 61(717):583-6. PubMed ID: 3161013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ketanserin on sodium nitroprusside requirements, arterial pressure control and heart rate following coronary artery bypass surgery.
    Hodsman NB; Colvin JR; Kenny GN
    Br J Anaesth; 1989 May; 62(5):527-31. PubMed ID: 2786422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized multicenter double-blind comparison of urapidil and ketanserin in hypertensive patients after coronary artery surgery.
    van der Stroom JG; van Wezel HB; Langemeijer JJ; Korsten HH; Kooyman J; van der Starre PJ; Kal JE; Porsius M; van den Ende R; van Zwieten PA
    J Cardiothorac Vasc Anesth; 1997 Oct; 11(6):729-36. PubMed ID: 9327314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic response to chronic ketanserin treatment in essential hypertension.
    Fagard R; Fiocchi R; Lijnen P; Staessen J; Amery A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S128-9. PubMed ID: 2412034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DA1-receptor stimulation by fenoldopam in the treatment of postcardiac surgical hypertension.
    Gombotz H; Plaza J; Mahla E; Berger J; Metzler H
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):834-40. PubMed ID: 9698961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitroglycerin infusion during coronary-artery surgery.
    Kaplan JA; Dunbar RW; Jones EL
    Anesthesiology; 1976 Jul; 45(1):14-21. PubMed ID: 820217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multicenter study with 3 different doses of ketanserin in essential arterial hypertension].
    Cruz J; Moscovici H; Silva AN; Finkielman S; Milei J; Geyer G; Feltkamp H; Stumpe KO; Berges LC
    Arq Bras Cardiol; 1985 Oct; 45(4):299-304. PubMed ID: 2940997
    [No Abstract]   [Full Text] [Related]  

  • 36. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
    Andrén L; Svensson A; Dahlöf B; Eggertsen R; Hansson L
    Acta Med Scand; 1983; 214(2):125-30. PubMed ID: 6353879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with ketanserin and ritanserin in hypertensive patients.
    Hedner T; Persson B
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S44-8. PubMed ID: 2459514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemodynamic effects of the new calcium antagonist nimodipine in normal and increased blood pressure].
    Engberding R; Bender F; Gülker H; Specker E; Molinski M
    Z Kardiol; 1984 Aug; 73(8):498-503. PubMed ID: 6495809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension.
    Fagard R; Fiocchi R; Lijnen P; Staessen J; Moerman E; de Schaepdryver A; Amery A
    Br Heart J; 1984 Feb; 51(2):149-56. PubMed ID: 6362688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension.
    Hedner T; Persson B
    Br J Clin Pharmacol; 1984 Nov; 18(5):765-71. PubMed ID: 6150724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.